Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

316
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
316
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Correlations02:20

Correlations

36.7K
Correlation means that there is a relationship between two or more variables (such as ice cream consumption and crime), but this relationship does not necessarily imply cause and effect. When two variables are correlated, it simply means that as one variable changes, so does the other. We can measure correlation by calculating a statistic known as a correlation coefficient. A correlation coefficient is a number from -1 to +1 that indicates the strength and direction of the relationship between...
36.7K
Self-Discrepancy Theory02:45

Self-Discrepancy Theory

19.0K
One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.  
19.0K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

981
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
981

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same author

Evaluation of a PET Insert for Trimodal Imaging: A Step Toward PET/MRI-Guided Focused Ultrasound.

IEEE transactions on radiation and plasma medical sciences·2026
Same author

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

ESMO open·2026
Same author

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

ESMO gastrointestinal oncology·2026
Same author

Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

ESMO gastrointestinal oncology·2026
Same author

Outcomes of Percutaneous Nephrolithotomy in Kidney Transplant Recipients: Results from a Multicenter Study by the Spanish Urology Association's Renal Transplant Group.

World journal of urology·2025

Related Experiment Video

Updated: Feb 27, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K

The Patient's Comorbidity Burden Correlates with the Erectile Dysfunction Severity.

E García-Cruz1, A Carrión2, T Ajami2

  • 1Departamento de Urología, Hospital Plató, Barcelona, España; Departamento of Urología, Hospital Clínic de Barcelona, Barcelona, España.

Actas Urologicas Espanolas
|June 24, 2017
PubMed
Summary

Erectile dysfunction (ED) severity is linked to higher comorbidity scores, but not strongly to testosterone levels. This suggests comorbidity, not just low testosterone, impacts overall health in men with ED.

Keywords:
Charlson Comorbidity IndexComorbidityComorbilidadDisfunción eréctilErectile dysfunctionHipogonadismoHypogonadismÍndice de comorbilidad de Charlson

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

966

Related Experiment Videos

Last Updated: Feb 27, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

966

Area of Science:

  • Andrology
  • Men's Health
  • Endocrinology

Background:

  • Erectile dysfunction (ED) is a common condition affecting men's health.
  • Low testosterone levels and comorbidities are frequently observed in men with ED.
  • The Charlson Comorbidity Index (CCI) is a validated measure of disease burden.

Purpose of the Study:

  • To investigate the relationship between erectile dysfunction (ED) severity, testosterone levels, and the Charlson Comorbidity Index (CCI).

Main Methods:

  • A cross-sectional study involving 430 men referred to andrology units.
  • ED was assessed using the International Index of Erectile Function (IIEF-5).
  • Total testosterone, comorbidities, and CCI were analyzed, with multiple linear regression used to assess predictors of CCI.

Main Results:

  • Increased ED severity correlated with lower testosterone (P=.002) and higher CCI (P<.001).
  • Testosterone was lower in men with obesity, diabetes, hypercholesterolemia, and hypertriglyceridemia.
  • ED severity significantly predicted CCI (P=.011), while testosterone levels did not (P=.204) in multivariate analysis.

Conclusions:

  • The Charlson Comorbidity Index (CCI) is significantly associated with erectile dysfunction (ED) severity.
  • Testosterone levels showed a weak correlation with the CCI score.
  • ED severity is a significant predictor of overall comorbidity burden in men.